RadNet Inc. (NASDAQ:RDNT) Director John V. Crues sold 20,000 shares of the business’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $10.08, for a total transaction of $201,600.00. Following the completion of the sale, the director now directly owns 563,781 shares of the company’s stock, valued at $5,682,912.48. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
Shares of RadNet Inc. (RDNT) traded down $0.40 on Friday, hitting $10.10. 283,782 shares of the stock traded hands, compared to its average volume of 207,137. RadNet Inc. has a 52-week low of $5.25 and a 52-week high of $11.90. The stock has a market cap of $478.62, a PE ratio of 32.67, a PEG ratio of 3.29 and a beta of 0.87. The company has a debt-to-equity ratio of 7.88, a current ratio of 1.29 and a quick ratio of 1.29.
RadNet (NASDAQ:RDNT) last announced its quarterly earnings results on Thursday, November 9th. The medical research company reported $0.12 earnings per share for the quarter, hitting the consensus estimate of $0.12. RadNet had a net margin of 1.21% and a return on equity of 23.73%. The firm had revenue of $227.60 million during the quarter, compared to analysts’ expectations of $232.84 million. During the same quarter in the prior year, the company earned $0.11 EPS. The company’s revenue was up 1.3% compared to the same quarter last year. equities analysts expect that RadNet Inc. will post 0.35 earnings per share for the current fiscal year.
RDNT has been the subject of several research reports. Zacks Investment Research cut shares of RadNet from a “hold” rating to a “sell” rating in a research report on Tuesday, November 14th. Jefferies Group raised shares of RadNet from a “hold” rating to a “buy” rating and boosted their price objective for the company from $7.00 to $12.00 in a research report on Tuesday, August 22nd. BidaskClub raised shares of RadNet from a “buy” rating to a “strong-buy” rating in a research report on Thursday, August 24th. Finally, TheStreet cut shares of RadNet from a “b-” rating to a “c” rating in a research report on Friday, October 27th.
RadNet Company Profile
RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.
Receive News & Ratings for RadNet Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet Inc. and related companies with MarketBeat.com's FREE daily email newsletter.